Estazolam

Estazolam.svg

Estazolam is a benzodiazepine derivative drug used primarily for the treatment of insomnia. It possesses anxiolytic, anticonvulsant, sedative, and muscle relaxant properties. Estazolam is marketed under various brand names, including ProSom.

Medical Uses

Estazolam is primarily prescribed for the short-term management of insomnia. It helps patients fall asleep faster, reduces the number of awakenings during the night, and increases the total sleep time. Due to its potential for dependence and tolerance, it is generally recommended for short-term use only.

Mechanism of Action

Estazolam works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased neuronal inhibition and produces the drug's sedative and anxiolytic effects.

Pharmacokinetics

Estazolam is well-absorbed from the gastrointestinal tract and reaches peak plasma concentrations within 2-3 hours after oral administration. It has a half-life of approximately 10-24 hours, which allows for once-daily dosing. The drug is metabolized in the liver and excreted primarily in the urine.

Side Effects

Common side effects of estazolam include drowsiness, dizziness, headache, and nausea. More severe side effects can include memory impairment, confusion, and coordination problems. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.

Contraindications

Estazolam is contraindicated in patients with a history of hypersensitivity to benzodiazepines, severe respiratory insufficiency, sleep apnea, and myasthenia gravis. It should be used with caution in patients with liver disease, renal impairment, and a history of substance abuse.

Interactions

Estazolam can interact with other central nervous system depressants, including alcohol, opioids, and other benzodiazepines, leading to enhanced sedative effects. It may also interact with medications that inhibit or induce cytochrome P450 enzymes, affecting its metabolism.

Legal Status

Estazolam is classified as a Schedule IV controlled substance under the Controlled Substances Act in the United States, indicating it has a lower potential for abuse and dependence compared to Schedule III substances.

See Also

• Benzodiazepine
• Insomnia
• Anxiolytic
• Sedative

Benzodiazipines

• Alprazolam
• Chlordiazepoxide
• Diazepam (Oral)
• Estazolam
• Flurazepam
• Lorazepam
• Midazolam
• Oxazepam
• Quazepam
• Temazepam
• Triazolam

Anticonvulsants Drugs

• Clobazam
• Clonazepam
• Clorazepate
• Diazepam (Intravenous)

Drug class for Estazolam

Anticonvulsants, and Benzodiazepines]

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian